Cargando…
SEOM clinical guidelines in Hereditary Breast and ovarian cancer
Approximately, 7 % of all breast cancers (BC) and 11–15 % of ovarian cancers (OC) are associated with inherited predisposition, mainly related to germline mutations in high penetrance BRCA1/2 genes. Clinical criteria for genetic testing are based on personal and family history to estimate a minimum...
Autores principales: | Llort, G., Chirivella, I., Morales, R., Serrano, R., Sanchez, A. Beatriz, Teulé, A., Lastra, E., Brunet, J., Balmaña, J., Graña, B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689749/ https://www.ncbi.nlm.nih.gov/pubmed/26669313 http://dx.doi.org/10.1007/s12094-015-1435-3 |
Ejemplares similares
-
Clinical guideline seom: hereditary colorectal cancer
por: Guillén-Ponce, C., et al.
Publicado: (2015) -
SEOM clinical guideline on heritable TP53-related cancer syndrome (2022)
por: Sánchez-Heras, Ana Beatriz, et al.
Publicado: (2023) -
SEOM guideline in ovarian cancer 2014
por: Gonzalez-Martín, A., et al.
Publicado: (2014) -
SEOM clinical guideline in ovarian cancer (2020)
por: Redondo, A., et al.
Publicado: (2021) -
SEOM clinical guideline for treatment of kidney cancer (2017)
por: Gallardo, E., et al.
Publicado: (2017)